1. GlaxoSmithKline Consumer Healthcare Limited
Financial Results
Q4 & FY 17-18

2. Quarter Highlights Revenue decreased by -2.5% : Underlying +8%
On account of change in tax rate & tax regime: Excise, Value Added Tax (VAT) etc. have been subsumed into GST
18.3% increase in PBT
Continued investment behind brands: 15% of Sales to fund innovation & drive Hlx campaign
Drive HFD Consumption
Brand building initiatives, continue to strengthen / expand the initiatives:
Strengthening Hunger campaign in South & East, Exam copy in West Bengal
Boost Campaign continues to do well
Sachets volume continue to grow high double digit, led by visible distribution & strong on-air support

3. Financial Performance*: Q4 FY17-18
*Sales and profit growth v/s quarter ending Mar 2017
INR in crores

4. Financial Performance*: FY17-18
*Sales and profit growth v/s year ending Mar 2017
INR in crores

5. Market Share Hlx 44.3% Horlicks Extensions 11.6% Boost 11.2%
Source – AC Nielsen; Value Market Share MAT Mar 18

6. Horlicks new visualization: ‘Defeating’ nutritional deficiencies

7. Thank You